Current Issue Cover

Volume 177: Issue 4
October 2017

Table of contents
Close contents    x

Editor's Choice

Secukinumab sustains good efficacy and favourable safety in moderate‐to‐severe psoriasis after up to 3 years of treatment: results from a double‐blind extension study

0

Favourite Read & review
Free Content

EDITORIALS

Introducing the new Evidence‐Based Dermatology section (Page 885 - 887)

Linked article

0

Favourite Read & Respond
Free Content

EDITORIALS

Systematic reviews: let’s keep them trustworthy (Page 888 - 889)

0

Favourite Read & Respond
Free Content

EDITORIALS

Personalized melanoma genomic risk information:perception of shared risk initiates sharing with family (Page 890 - 891)

0

Favourite Read & Respond

COMMENTARIES

Acne guidelines: pearls, pitfalls and questions (Page 892 - 893)

Linked article

0

Favourite Read & Respond

COMMENTARIES

A path through the reticulate pigmentation disorder jungle (Page 893 - 894)

Linked article

0

Favourite Read & Respond

COMMENTARIES

The evolving universe of BRAF mutations in melanoma (Page 893 - 893)

Linked article

0

Favourite Read & Respond

COMMENTARIES

Staphylococcus aureus and psoriasis: time for a re‐appraisal? (Page 894 - 895)

Linked article

0

Favourite Read & Respond

COMMENTARIES

Sequence variants in hidradenitis suppurativa: in search of the pathogenic mechanisms (Page 895 - 896)

Linked article

0

Favourite Read & Respond

COMMENTARIES

Further progress for therapeutic solutions in psoriasis (Page 896 - 897)

Linked article

0

Favourite Read & Respond

COMMENTARIES

First‐line systemic treatment of psoriasis: staying conventional or going biologic? (Page 897 - 898)

Linked article

0

Favourite Read & Respond

COMMENTARIES

Cardiometabolic disease in atopic dermatitis: the heart of the matter (Page 898 - 899)

Linked article

0

Favourite Read & Respond

COMMENTARIES

Getting tired of psoriasis? (Page 899 - 900)

Linked article

0

Favourite Read & Respond

COMMENTARIES

Clinical significance of parvovirus B19 DNA in cutaneous biopsies (Page 900 - 901)

Linked article

0

Favourite Read & Respond

COMMENTARIES

Towards the use of precision medicine in predicting cutaneous squamous cell carcinoma risk among solid organ transplant recipients (Page 901 - 902)

Linked article

0

Favourite Read & Respond

COMMENTARIES

Endoscopic characteristics of oesophagus involvement in mucous membrane pemphigoid (Page 902 - 903)

Linked article

0

Favourite Read & Respond

COMMENTARIES

Towards a better categorization of patients with chronic urticaria (Page 903 - 904)

Linked article

0

Favourite Read & Respond

COMMENTARIES

Cost‐effectiveness of HLA‐B*15:02 screening in Malaysia (Page 904 - 905)

Linked article

Media

bjd15832-sup-0001-AudioS1.mp3

0

Favourite Read & Respond

COMMENTARIES

Unravelling the links between malignancy, cytokines and neutrophilic eruptions (Page 905 - 906)

Linked article

0

Favourite Read & Respond

COMMENTARIES

A foot tumour as late cutaneous Lyme borreliosis: a new entity or a variant of an inflammatory proliferative reaction to Borrelia burgdorferi ? (Page 906 - 907)

Linked article

0

Favourite Read & Respond

GUIDELINES

Guidelines for the management of acne: recommendations from a French multidisciplinary group (Page 908 - 913)

Commentary or Editorial available

0

Favourite Read & Respond

REVIEW ARTICLES

BRAF inhibitor‐associated cutaneous squamous cell carcinoma: new mechanistic insight, emerging evidence for viral involvement and perspectives on clinical management (Page 914 - 923)

0

Favourite Read & Respond

REVIEW ARTICLES

Long‐term complications of Stevens–Johnson syndrome/toxic epidermal necrolysis ( SJS / TEN ): the spectrum of chronic problems in patients who survive an episode of SJS / TEN necessitates multidisciplinary follow‐up (Page 924 - 935)

Plain Language Summary available

0

Favourite Read & Respond

REVIEW ARTICLES

Beyond the BRAF V 600E hotspot: biology and clinical implications of rare BRAF gene mutations in melanoma patients (Page 936 - 944)

Commentary or Editorial available

0

Favourite Read & Respond

REVIEW ARTICLES

Updated review of genetic reticulate pigmentary disorders (Page 945 - 959)

Commentary or Editorial available

0

Favourite Read & Respond

SYSTEMATIC REVIEWS

Not every patient needs a triglyceride check, but all can get pancreatitis: a systematic review and clinical characterization of isotretinoin‐associated pancreatitis (Page 960 - 966)

Plain Language Summary available

0

Favourite Read & Respond

SYSTEMATIC REVIEWS

Risks for Staphylococcus aureus colonization in patients with psoriasis: a systematic review and meta‐analysis (Page 967 - 977)

Commentary or Editorial available

Media

bjd15366-sup-0002-VideoS1.mp4

0

Favourite Read & Respond

SYSTEMATIC REVIEWS

Relative risk of and determinants for adverse events of methotrexate prescribed at a low dose: a systematic review and meta‐analysis of randomized placebo‐controlled trials (Page 978 - 986)

0

Favourite Read & Respond

SYSTEMATIC REVIEWS

A systematic review and critical evaluation of reported pathogenic sequence variants in hidradenitis suppurativa (Page 987 - 998)

Commentary or Editorial available

Media

bjd15441-sup-0004-VideoS1.mp4

0

Favourite Read & Respond

CRITICALLY APPRAISED RESEARCH PAPER

A 5‐year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal (Page 999 - 1003)

0

Favourite Read & Respond

CRITICALLY APPRAISED RESEARCH PAPER

A 5‐year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal – comment (Page 1004 - 1005)

0

Favourite Read & Respond

CRITICALLY APPRAISED RESEARCH PAPER

A 5‐year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal – author response (Page 1006 - 1006)

0

Favourite Read & Respond

CRITICALLY APPRAISED TOPIC

How to write a Critically Appraised Topic: evidence to underpin routine clinical practice (Page 1007 - 1013)

0

Favourite Read & Respond

CLINICAL TRIALS

Comparison of ixekizumab with ustekinumab in moderate‐to‐severe psoriasis: 24‐week results from IXORA ‐S, a phase III study (Page 1014 - 1023)

Commentary or Editorial available

0

Favourite Read & Respond

CLINICAL TRIALS

Secukinumab is superior to fumaric acid esters in treating patients with moderate‐to‐severe plaque psoriasis who are naive to systemic treatments: results from the randomized controlled PRIME trial (Page 1024 - 1032)

Commentary or Editorial available

Media

bjd15707-sup-0002-VideoS1.mp4

0

Favourite Read & Respond

CLINICAL TRIALS

Secukinumab sustains good efficacy and favourable safety in moderate‐to‐severe psoriasis after up to 3 years of treatment: results from a double‐blind extension study (Page 1033 - 1042)

0

Favourite Read & Respond

EPIDEMIOLOGY

Atopic dermatitis and risk of hypertension, type 2 diabetes, myocardial infarction and stroke in a cross‐sectional analysis from the Canadian Partnership for Tomorrow Project (Page 1043 - 1051)

Commentary or Editorial available

Plain Language Summary available

Media

bjd15727-sup-0002-videoS1.mp4

0

Favourite Read & Respond

QUALITATIVE AND OUTCOMES RESEARCH

A cross‐sectional survey of the nature and correlates of sleep disturbance in people with psoriasis (Page 1052 - 1059)

Commentary or Editorial available

Plain Language Summary available

0

Favourite Read & Respond

TRANSLATIONAL RESEARCH

Detection of human parvovirus B19 DNA in 22% of 1815 cutaneous biopsies of a wide variety of dermatological conditions suggests viral persistence after primary infection and casts doubts on its pathogenic significance (Page 1060 - 1065)

Commentary or Editorial available

Plain Language Summary available

0

Favourite Read & Respond

TRANSLATIONAL RESEARCH

Variants at the OCA 2 / HERC 2 locus affect time to first cutaneous squamous cell carcinoma in solid organ transplant recipients collected using two different study designs (Page 1066 - 1073)

Commentary or Editorial available

Media

bjd15618-sup-0001-VideoS1.MOV

0

Favourite Read & Respond

MEDICAL DERMATOLOGY

Oesophageal involvement in 26 consecutive patients with mucous membrane pemphigoid (Page 1074 - 1085)

Commentary or Editorial available

Plain Language Summary available

0

Favourite Read & Respond

PAEDIATRIC DERMATOLOGY

Evaluation of the reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index and the Cutaneous Assessment Tool–Binary Method in juvenile dermatomyositis among paediatric dermatologists, rheumatologists and neurologists (Page 1086 - 1092)

0

Favourite Read & Respond

GENERAL DERMATOLOGY

Analysis of disease activity categories in chronic spontaneous/idiopathic urticaria (Page 1093 - 1101)

Commentary or Editorial available

Plain Language Summary available

Media

bjd15454-sup-0002-videoS1.mp4

0

Favourite Read & Respond

GENERAL DERMATOLOGY

Is universal HLA ‐B*15:02 screening a cost‐effective option in an ethnically diverse population? A case study of Malaysia (Page 1102 - 1112)

Commentary or Editorial available

Media

bjd15498-sup-0002-VideoS1.mp4

0

Favourite Read & Respond

GENERAL DERMATOLOGY

Occurrence of metachronous basal cell carcinomas: a prognostic model (Page 1113 - 1121)

0

Favourite Read & Respond

CLINICAL AND DIAGNOSTIC

Case report of multiple pustules of the bilateral lower limbs caused by a granulocyte colony‐stimulating factor‐producing solid pseudopapillary tumour of the pancreas (Page 1122 - 1126)

Commentary or Editorial available

0

Favourite Read & Respond

CLINICAL AND DIAGNOSTIC

A foot tumour as late cutaneous Lyme borreliosis: a new entity? (Page 1127 - 1130)

Commentary or Editorial available

0

Favourite Read & Respond

RESEARCH LETTERS

An evaluation of high‐stage cutaneous squamous cell carcinoma outcomes by sex (Page 1131 - 1133)

0

Favourite Read & Respond

RESEARCH LETTERS

The relationship between disease severity and quality of life in discoid lupus erythematosus (Page 1134 - 1135)

0

Favourite Read & Respond

LETTERS TO THE EDITOR

Response to: M.F. Holick ‘Can you have your cake and eat it too? The sunlight D‐lema’ (Page 1136 - 1136)

0

Favourite Read & Respond

LETTERS TO THE EDITOR

Reply to Whiteman et al .: In‐Deed wise to get some sensible sun exposure (Page 1136 - 1137)

0

Favourite Read & Respond

OBITUARIES

Stephen Charles Gold MD FRCP 1915–2017 (Page 1137 - 1138)

0

Favourite Read & Respond

OBITUARIES

Dr Yvonne Mukasa 1977–2016 (Page 1138 - 1139)

0

Favourite Read & Respond

News and Notices

News and Notices (Page 1139 - 1141)

0

Favourite Read & Respond
Free Content

IMAGE CORRESPONDENCE

Cover Image: Capturing the architectural beauty of the dermal elastic fibre network (Page 1141 - 1142)

0

Favourite Read & Respond

Close